Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Rapid Micro Biosystems, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q2 2023
- Shares held
- 21.5M
- −416.4K (−1.9%) vs. Q2 2023
- Total value
- $23.2M
- +$1.30M (+5.9%) vs. Q2 2023
- New holders
- 1
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | +4 | New |
| Wells Fargo & Company | 146 | $158 | 0.00% | +62+73.8% | Added |
| Resources Management Corp | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,152 | $3.40K | 0.00% | −710−18.4% | Reduced |
| Morgan Stanley | 10,644 | $11.5K | 0.00% | +436+4.3% | Added |
| Schonfeld Strategic Advisors LLC | 15,000 | $16.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,641 | $18.0K | 0.00% | −33,095−66.5% | Reduced |
| Northern Trust Corp | 18,944 | $20.5K | 0.00% | −2,571−11.9% | Reduced |
| Renaissance Technologies LLC | 22,387 | $24.0K | 0.00% | −5,379−19.4% | Reduced |
| Parkwood LLC | 24,511 | $26.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 24,985 | $27.0K | 0.00% | −18,787−42.9% | Reduced |
| State Street Corp | 26,074 | $28.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 155,264 | $167.7K | 0.00% | +58,616+60.6% | Added |
| Advent International Corp | 577,777 | $624.0K | 0.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $756.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 726,024 | $784.1K | 0.00% | −3,576−0.5% | Reduced |
| Goldman Sachs Group Inc | 947,781 | $1.02M | 0.00% | +6,424+0.7% | Added |
| BlackRock Inc. | 1,022,118 | $1.10M | 0.00% | −12,743−1.2% | Reduced |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $1.12M | 5.38% | 00.0% | Unchanged |
| Glenview Capital Management, LLC | 1,318,288 | $1.42M | 0.04% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,434,228 | $1.55M | 0.00% | −1,479−0.1% | Reduced |
| Kennedy Lewis Management LP | 4,939,931 | $5.34M | 25.51% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $9.11M | 1.02% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −403,284−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −339−100.0% | Sold out |